Systemic Therapy for Small-Cell Lung Cancer : ASCO-Ontario Health (Cancer Care Ontario) Guideline
PURPOSE: To provide evidence-based recommendations to practicing clinicians on the management of patients with small-cell lung cancer.
METHODS: An Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary, community oncology, research methodology, and advocacy experts were convened to conduct a literature search, which included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2022. Outcomes of interest included response rates, overall survival, disease-free survival or recurrence-free survival, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations.
RESULTS: The literature search identified 95 relevant studies to inform the evidence base for this guideline.
RECOMMENDATIONS: Evidence-based recommendations were developed to address systemic therapy options, timing of therapy, treatment in patients who are older or with poor performance status, role of biomarkers, and use of myeloid-supporting agents in patients with small-cell lung cancer.Additional information is available at www.asco.org/thoracic-cancer-guidelines.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 41(2023), 35 vom: 10. Dez., Seite 5448-5472 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Khurshid, Humera [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 04.01.2024 Date Revised 04.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1200/JCO.23.01435 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363133739 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363133739 | ||
| 003 | DE-627 | ||
| 005 | 20240108141637.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.23.01435 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1248.xml |
| 035 | |a (DE-627)NLM363133739 | ||
| 035 | |a (NLM)37820295 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Khurshid, Humera |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Systemic Therapy for Small-Cell Lung Cancer |b ASCO-Ontario Health (Cancer Care Ontario) Guideline |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.01.2024 | ||
| 500 | |a Date Revised 04.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a PURPOSE: To provide evidence-based recommendations to practicing clinicians on the management of patients with small-cell lung cancer | ||
| 520 | |a METHODS: An Expert Panel of medical oncology, thoracic surgery, radiation oncology, pulmonary, community oncology, research methodology, and advocacy experts were convened to conduct a literature search, which included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2022. Outcomes of interest included response rates, overall survival, disease-free survival or recurrence-free survival, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations | ||
| 520 | |a RESULTS: The literature search identified 95 relevant studies to inform the evidence base for this guideline | ||
| 520 | |a RECOMMENDATIONS: Evidence-based recommendations were developed to address systemic therapy options, timing of therapy, treatment in patients who are older or with poor performance status, role of biomarkers, and use of myeloid-supporting agents in patients with small-cell lung cancer.Additional information is available at www.asco.org/thoracic-cancer-guidelines | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 700 | 1 | |a Ismaila, Nofisat |e verfasserin |4 aut | |
| 700 | 1 | |a Bian, Jessica |e verfasserin |4 aut | |
| 700 | 1 | |a Dabney, Raetasha |e verfasserin |4 aut | |
| 700 | 1 | |a Das, Millie |e verfasserin |4 aut | |
| 700 | 1 | |a Ellis, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Feldman, Jill |e verfasserin |4 aut | |
| 700 | 1 | |a Hann, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Kulkarni, Swati |e verfasserin |4 aut | |
| 700 | 1 | |a Laskin, Janessa |e verfasserin |4 aut | |
| 700 | 1 | |a Manochakian, Rami |e verfasserin |4 aut | |
| 700 | 1 | |a Mishra, Deebya Raj |e verfasserin |4 aut | |
| 700 | 1 | |a Preeshagul, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Reddy, Pavan |e verfasserin |4 aut | |
| 700 | 1 | |a Saxena, Ashish |e verfasserin |4 aut | |
| 700 | 1 | |a Weinberg, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Kalemkerian, Gregory P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology : official journal of the American Society of Clinical Oncology |d 1986 |g 41(2023), 35 vom: 10. Dez., Seite 5448-5472 |w (DE-627)NLM012608777 |x 1527-7755 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2023 |g number:35 |g day:10 |g month:12 |g pages:5448-5472 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.23.01435 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2023 |e 35 |b 10 |c 12 |h 5448-5472 | ||